Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Determination Of The 90% Effective Sedation Dose Of Midazolam In Patients Undergoing Diagnostic Upper Gastric-Endoscopy

NCT03813043 is registered in ClinicalTrials.gov with King Fahad Specialist Hospital Dammam as lead sponsor.

NCT NCT03813043
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03813043 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Determination Of The 90% Effective Sedation Dose Of Midazolam In Patients Undergoing Diagnostic Upper Gastric-Endoscopy
Lead sponsor
King Fahad Specialist Hospital Dammam
Phase
Not applicable
Overall status
Unknown status
Start date
February 15, 2019
Completion date
December 15, 2019
Enrollment
40 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

gastro-esophageal reflux disease with ulceration